D P Joyce1, R A McIvor. 1. Department of Respiratory Disease, Sunnybrook Health Sciences Centre, Toronto, ON.
Abstract
OBJECTIVE: To determine asthma patients' patterns of disease and knowledge of asthma. DESIGN: Telephone survey of patients with diagnosed asthma. SETTING: Residences in 10 Canadian provinces. PARTICIPANTS: Patients with asthma diagnosed by a doctor: 829 men and women with a mean age of 38 +/- 7 years. MAIN OUTCOME MEASURES: Classes of asthma medications, patterns of use, frequency and severity of asthma symptoms use of emergency departments and urgent medical services, participation in asthma education programs, presence of environmental triggers, and knowledge of asthma pathophysiology and treatment. RESULTS: Four hundred fifty-six patients (55%) reported daily symptoms of asthma; 431 patients (52%) used inhaled beta 2-agonists daily. Only 340 patients (41%) used inhaled corticosteroids (IC), and many used them irregularly. A total of 579 (72%) respondents reported no unscheduled visits to a family physician for worsening asthma, but one third of patients had been to an emergency department for uncontrolled asthma in the last 5 years, and most of these visits had occurred during the last year. As to knowledge, 406 patients (49%) disagreed with the statement that asthma is a lifelong condition that cannot be cured. Among IC users, only 101 (30%) knew that IC reduced airway inflammation; among beta 2-agonist users, only 33% agreed that beta 2-agonists opened the bronchial tubes. Two hundred forty patients (29%) reported being current cigarette smokers, and 381 (46%) reported having pets at home. CONCLUSIONS: Daily symptoms and daily use of beta 2-agonists are common among Canadian asthma patients, and this is in excess of what is considered acceptable by current asthma care guidelines. Underuse of IC, inadequate knowledge of asthma symptoms and treatments, and failure to avoid asthma triggers were common in the population studied.
OBJECTIVE: To determine asthmapatients' patterns of disease and knowledge of asthma. DESIGN: Telephone survey of patients with diagnosed asthma. SETTING: Residences in 10 Canadian provinces. PARTICIPANTS: Patients with asthma diagnosed by a doctor: 829 men and women with a mean age of 38 +/- 7 years. MAIN OUTCOME MEASURES: Classes of asthma medications, patterns of use, frequency and severity of asthma symptoms use of emergency departments and urgent medical services, participation in asthma education programs, presence of environmental triggers, and knowledge of asthma pathophysiology and treatment. RESULTS: Four hundred fifty-six patients (55%) reported daily symptoms of asthma; 431 patients (52%) used inhaled beta 2-agonists daily. Only 340 patients (41%) used inhaled corticosteroids (IC), and many used them irregularly. A total of 579 (72%) respondents reported no unscheduled visits to a family physician for worsening asthma, but one third of patients had been to an emergency department for uncontrolled asthma in the last 5 years, and most of these visits had occurred during the last year. As to knowledge, 406 patients (49%) disagreed with the statement that asthma is a lifelong condition that cannot be cured. Among IC users, only 101 (30%) knew that IC reduced airway inflammation; among beta 2-agonist users, only 33% agreed that beta 2-agonists opened the bronchial tubes. Two hundred forty patients (29%) reported being current cigarette smokers, and 381 (46%) reported having pets at home. CONCLUSIONS: Daily symptoms and daily use of beta 2-agonists are common among Canadian asthmapatients, and this is in excess of what is considered acceptable by current asthma care guidelines. Underuse of IC, inadequate knowledge of asthma symptoms and treatments, and failure to avoid asthma triggers were common in the population studied.
Authors: T Haahtela; M Järvinen; T Kava; K Kiviranta; S Koskinen; K Lehtonen; K Nikander; T Persson; K Reinikainen; O Selroos Journal: N Engl J Med Date: 1991-08-08 Impact factor: 91.245
Authors: J Mark FitzGerald; Louis-Philipe Boulet; R Andrew McIvor; Sabrina Zimmerman; Kenneth R Chapman Journal: Can Respir J Date: 2006 Jul-Aug Impact factor: 2.409
Authors: Robert L Cowie; Margot F Underwood; Don D Sin; Heather M Sharpe; Neil R Bell; S F Paul Man Journal: Can Fam Physician Date: 2006-06 Impact factor: 3.275
Authors: R Andrew McIvor; Louis-Philippe Boulet; J Mark FitzGerald; Sabrina Zimmerman; Kenneth R Chapman Journal: Can Fam Physician Date: 2007-04 Impact factor: 3.275
Authors: Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas Journal: Can Respir J Date: 2006-03 Impact factor: 2.409
Authors: Joaquin Sastre; Leonardo M Fabbri; David Price; Hans Ulrich Wahn; Jean Bousquet; James E Fish; Kevin Murphy; Malcolm R Sears Journal: World Allergy Organ J Date: 2016-05-04 Impact factor: 4.084